Evelo Biosciences Inc EDP1815 Clinical Data Update Call Transcript
Good morning, and welcome to the Evelo Biosciences Conference Call to discuss top line clinical data from a Phase II study of EDP1815 in psoriasis. (Operator Instructions) Please be advised that today's call is being recorded at the company's request. At this time, I'd like to turn the call over to Jessica Cotrone of Evelo. Please proceed. .
Thank you. This morning, we issued a press release that outlines the topics we plan to discuss today. This release, along with a webcast link for today's presentation is available at www.evelobio.com under the Investors tab. We urge you to join today's call through the webcast so that you can follow along with our slides in real time. Today on our call, Simba Gill, Chief Executive Officer; Jonathan Zung, Chief Development Officer; Douglas Maslin, EDP1815 Medical Lead and Dermatologists and Dr. Benjamin Ehst, Board-Certified Dermatologist, Investigator and Clinical Associate Professor
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |